Evaluation of the efficacy of pirfenidone in progressive chronic hypersensitivity pneumonitis
Abstract Background The present data about the treatment of progressive CHP are few and largely based on observational studies and expert opinion. It is suggested that pirfenidone may slow disease progression in cases of CHP as it has some anti-inflammatory in addition to antifibrotic effects, so th...
Main Authors: | Eman Shebl, Tarek Hamdy |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-03-01
|
Series: | The Egyptian Journal of Bronchology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43168-021-00065-y |
Similar Items
-
No effect of pirfenidone treatment in fulminant bleomycin-induced pneumonitis
by: Elisabeth Bendstrup, et al.
Published: (2014-01-01) -
Establishment and Characterization of a Novel Fibroblastic Cell Line (SCI13D) Derived from the Broncho-Alveolar Lavage of a Patient with Fibrotic Hypersensitivity Pneumonitis
by: Paolo Giannoni, et al.
Published: (2021-09-01) -
Phenytoin-induced acute hypersensitivity pneumonitis
by: Pallavi Periwal, et al.
Published: (2015-01-01) -
Treatment of steroid‐resistant checkpoint inhibitor pneumonitis with pirfenidone: A case report
by: Kang Miao, et al.
Published: (2021-08-01) -
Chronic hypersensitivity pneumonitis
by: Pereira CA, et al.
Published: (2016-09-01)